Contract Signed With….....a strong "but" and significant caveat. I would call this NR, neutral. Some of that rationale is based on the reality that codes don't go into effect until October 1, 2024 and the distributor has an out (which makes sense).
There's no reason for the sp to go down on this news unless a disproportionate number of day traders decide to accept less of a profit and move their shares elsewhere in the short term. Is the news enough to catapult the so in a positive direction ....probably not more than a penny or two. But longs have every reason to remain so on this NR alone.
The upside is that while the risk is low for the distributor in this arrangement, why bother putting the time and money into diverting sales staff away from other product offerings if you don't seriously believe in Venowave. With units ready to sell, scientific research that demonstrates the product is second to none and code pricing that essentially covers the whole cost of the device, expected sales of all the devices seems a no brainer. There is absolutely no risk to the patient or the distributor.
It may take until the end of the year and a couple of months of selling to get a real sense of where this is all going but at this point in time ....all seems very bright for Therma Briight.
GLTE!!!